Literature DB >> 27530208

[SCS as a treatment option for failed back surgery syndrome].

V Tronnier1.   

Abstract

Unfortunately, 10-40 % of patients still experience pain after spinal surgery. There are many reasons for the patients' complaints. If no identifiable cause, such as a recurrent disc herniation, is visible, this is referred to as failed back surgery syndrome. However, this definition includes a variety of possible underlying causes of the pain, which result in just as many different therapeutic approaches. In addition to pharmacological, behavioral and physical therapy, also neuromodulation techniques can be offered; the best known method is spinal cord stimulation (SCS). The following article describes evidence-based studies with regard to the beneficial treatment of failed back surgery syndrome with conventional tonic SCS and new developments in spinal cord stimulation addressing the treatment of chronic refractory back pain.

Entities:  

Keywords:  Chronic back pain; Dorsal root ganglion; Failed back surgery syndrome; Postoperative pain; Spinal cord stimulation

Mesh:

Year:  2016        PMID: 27530208     DOI: 10.1007/s00132-016-3310-5

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  42 in total

1.  Spinal cord stimulation versus repeated lumbosacral spine surgery for chronic pain: a randomized, controlled trial.

Authors:  Richard B North; David H Kidd; Farrokh Farrokhi; Steven A Piantadosi
Journal:  Neurosurgery       Date:  2005       Impact factor: 4.654

2.  Stimulation of dorsal root ganglia for the management of complex regional pain syndrome: a prospective case series.

Authors:  Jean-Pierre Van Buyten; Iris Smet; Liong Liem; Marc Russo; Frank Huygen
Journal:  Pain Pract       Date:  2014-01-23       Impact factor: 3.183

Review 3.  Neuropathic pain: principles of diagnosis and treatment.

Authors:  Ian Gilron; Ralf Baron; Troels Jensen
Journal:  Mayo Clin Proc       Date:  2015-04       Impact factor: 7.616

4.  Failed back surgery syndrome - definition, epidemiology and demographics.

Authors:  Simon Thomson
Journal:  Br J Pain       Date:  2013-02

5.  Comparison of intensity-dependent inhibition of spinal wide-dynamic range neurons by dorsal column and peripheral nerve stimulation in a rat model of neuropathic pain.

Authors:  F Yang; Q Xu; Y-K Cheong; R Shechter; A Sdrulla; S-Q He; V Tiwari; X Dong; P W Wacnik; R Meyer; S N Raja; Y Guan
Journal:  Eur J Pain       Date:  2014-01-06       Impact factor: 3.931

Review 6.  Counting the costs: case management implications of spinal cord stimulation treatment for failed back surgery syndrome.

Authors:  Nagy Mekhail; Donald L Wentzel; Robert Freeman; Hafsa Quadri
Journal:  Prof Case Manag       Date:  2011 Jan-Feb

7.  Treatment of low back pain: Second extended follow up of an original trial (NCT00600197) comparing a multidisciplinary group-based rehabilitation program with oral drug treatment alone up to 30 months.

Authors:  Sedigheh S Tavafian; Ahmad R Jamshidi; Kazem Mohammad
Journal:  Int J Rheum Dis       Date:  2014-12-26       Impact factor: 2.454

8.  Practice guidelines for chronic pain management: an updated report by the American Society of Anesthesiologists Task Force on Chronic Pain Management and the American Society of Regional Anesthesia and Pain Medicine.

Authors: 
Journal:  Anesthesiology       Date:  2010-04       Impact factor: 7.892

9.  Paresthesia-Free High-Density Spinal Cord Stimulation for Postlaminectomy Syndrome in a Prescreened Population: A Prospective Case Series.

Authors:  Jennifer Sweet; Anish Badjatiya; Daniel Tan; Jonathan Miller
Journal:  Neuromodulation       Date:  2015-10-20

10.  Peripheral nerve field stimulation (PNFS) in chronic low back pain: a prospective multicenter study.

Authors:  Herwig Kloimstein; Rudolf Likar; Michael Kern; Josef Neuhold; Miroslav Cada; Nadja Loinig; Wilfried Ilias; Brigitta Freundl; Heinrich Binder; Andreas Wolf; Christian Dorn; Eva Maria Mozes-Balla; Rolf Stein; Ivo Lappe; Sabine Sator-Katzenschlager
Journal:  Neuromodulation       Date:  2013-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.